Back to Search
Start Over
The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa
- Source :
- Cellular and Molecular Gastroenterology and Hepatology, Cellular and Molecular Gastroenterology and Hepatology, 2020, 9 (2), pp.257-276. ⟨10.1016/j.jcmgh.2019.10.007⟩, Cellular and Molecular Gastroenterology and Hepatology 9(2), Kérwá, Universidad de Costa Rica, instacron:UCR, Cellular and Molecular Gastroenterology and Hepatology, Philadelphia, PA : American Gastroenterological Association, [2015]-, 2020, 9 (2), pp.257-276. ⟨10.1016/j.jcmgh.2019.10.007⟩, Cellular and Molecular Gastroenterology and Hepatology, Vol 9, Iss 2, Pp 257-276 (2020)
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
-
Abstract
- Background & Aims Gastric carcinoma is related mostly to CagA+-Helicobacter pylori infection, which disrupts the gastric mucosa turnover and elicits an epithelial-mesenchymal transition (EMT) and preneoplastic transdifferentiation. The tumor suppressor Hippo pathway controls stem cell homeostasis; its core, constituted by the large tumor suppressor 2 (LATS2) kinase and its substrate Yes-associated protein 1 (YAP1), was investigated in this context. Methods Hippo, EMT, and intestinal metaplasia marker expression were investigated by transcriptomic and immunostaining analyses in human gastric AGS and MKN74 and nongastric immortalized RPE1 and HMLE epithelial cell lines challenged by H pylori, and on gastric tissues of infected patients and mice. LATS2 and YAP1 were silenced using small interfering RNAs. A transcriptional enhanced associated domain (TEAD) reporter assay was used. Cell proliferation and invasion were evaluated. Results LATS2 and YAP1 appear co-overexpressed in the infected mucosa, especially in gastritis and intestinal metaplasia. H pylori via CagA stimulates LATS2 and YAP1 in a coordinated biphasic pattern, characterized by an early transient YAP1 nuclear accumulation and stimulated YAP1/TEAD transcription, followed by nuclear LATS2 up-regulation leading to YAP1 phosphorylation and targeting for degradation. LATS2 and YAP1 reciprocally positively regulate each other’s expression. Loss-of-function experiments showed that LATS2 restricts H pylori–induced EMT marker expression, invasion, and intestinal metaplasia, supporting a role of LATS2 in maintaining the epithelial phenotype of gastric cells and constraining H pylori–induced preneoplastic changes. Conclusions H pylori infection engages a number of signaling cascades that alienate mucosa homeostasis, including the Hippo LATS2/YAP1/TEAD pathway. In the host–pathogen conflict, which generates an inflammatory environment and perturbations of the epithelial turnover and differentiation, Hippo signaling appears as a protective pathway, limiting the loss of gastric epithelial cell identity that precedes gastric carcinoma development.<br />Graphical abstract
- Subjects :
- Male
0301 basic medicine
[SDV]Life Sciences [q-bio]
Cell Cycle Proteins
Mice
CDX2, caudal-type homeobox protein 2
0302 clinical medicine
KRT7, keratin 7
RT-qPCR, reverse-transcription quantitative polymerase chain reaction
IAP, intestinal alkaline phosphatase
Original Research
Aged, 80 and over
VGLL4, vestigial-like family member 4
YAP1
Transdifferentiation
Gastroenterology
siControl, small interference RNA Control
Intestinal metaplasia
mRNA, messenger RNA
3. Good health
Gene Expression Regulation, Neoplastic
CagA
[SDV] Life Sciences [q-bio]
Editorial
medicine.anatomical_structure
Hippo signaling
Host-Pathogen Interactions
LATS2, large tumor suppressor 2
Long-Acting Thyroid Stimulator
Female
ZEB1, Zinc finger E-box-binding homeobox 1
030211 gastroenterology & hepatology
Signal Transduction
Epithelial-Mesenchymal Transition
cagPAI, cytotoxin-associated gene A-Pathogenicity Island
NF-κB, nuclear factor-κB
Protein Serine-Threonine Kinases
Adenocarcinoma
Biology
Helicobacter Infections
HPI, Helicobacter pylori infection
CTGF, conective tissue growth factor
Viral Proteins
03 medical and health sciences
BMP1, bone morphogenic protein-1
HMLE, human mammary epithelial cells
Stomach Neoplasms
Epithelial-to-Mesenchymal Transition
medicine
Gastric mucosa
Animals
Humans
Hippo Signaling Pathway
GC, gastric adenocarcinoma
Epithelial–mesenchymal transition
Dancing
lcsh:RC799-869
Aged
Adaptor Proteins, Signal Transducing
Metaplasia
Hippo signaling pathway
TEAD, transcriptional enhanced associated domain
Helicobacter pylori
Hepatology
Tumor Suppressor Proteins
Membrane Proteins
YAP-Signaling Proteins
MMP9, matrix metalloproteinase 9
Protective Factors
MST1/2, Mammalian Ste20-like kinases 1/2
medicine.disease
WT, wild-type
MUC2, mucin 2
030104 developmental biology
Gastric Mucosa
Cancer research
lcsh:Diseases of the digestive system. Gastroenterology
RPE1, retinal pigment epithelial cells
Precancerous Conditions
Ca-Mg, 1 mmol/L CaCl2 and 1 mmol/L MgCl2
EMT, epithelial-to-mesenchymal transition
Transcription Factors
Subjects
Details
- ISSN :
- 2352345X
- Volume :
- 9
- Database :
- OpenAIRE
- Journal :
- Cellular and Molecular Gastroenterology and Hepatology
- Accession number :
- edsair.doi.dedup.....be896e418fc10c8566166d6137999770
- Full Text :
- https://doi.org/10.1016/j.jcmgh.2019.10.007